Hiroaki Wakiyama

13PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 17, 2023
Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.

Hiroshi Fukushima, Aki Furusawa, Takuya Kato

|Nov 21, 2022
Near infrared photoimmunotherapy of cancer; possible clinical applications.

Hiroaki Wakiyama, Takuya Kato, Aki Furusawa

|Oct 12, 2022
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts.

Takuya Kato, Aki Furusawa, Ryuhei Okada

|Sep 28, 2022
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy.

Hiroaki Wakiyama, Takuya Kato, Aki Furusawa

|Jun 20, 2022
Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer.

Hiroshi Fukushima, Takuya Kato, Aki Furusawa

Pageof 3